About Doer

    Zhejiang Doer Biologics Co., Ltd. was established on April 1, 2014, with a registered capital of 52.12 million yuan. The company is a high-tech enterprise specializing in innovative biopharmaceutical development under Huadong Medicine (stock code: SZ.000963). Its R&D center is located in the Hangzhou Medicine Port Town.

    Group Photo of Dr. Junfang Xu, Dr. Yongliang Fang, and Prof. Jianping Li's Team at the AHA 2025 Conference
    Dr. Yongliang Fang Attends EASL 2025
    DR510 Debuts at the ESMO 2025 Congress

    Technology

    Technology platform

    xLONGylation®--recombinant PEG-like polypeptide platform

    xLONGylation®--recombinant PEG-like polypeptide platform

    MultipleBody®--Multi-targeted biotherapeutics

    MultipleBody®--Multi-targeted biotherapeutics

    AccuBody®--Accurately activated antibody for precision tumor therapy

    AccuBody®--Accurately activated antibody for precision tumor therapy

    News

    News Center